Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers? - Summary - MDSpire
From the Journals

Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?

A systematic review and meta-analysis found that early time-of-day immunotherapy was associated with improved survival outcomes in patients with advanced cancers, with the association appearing to be ...

  • By

  • The ASCO Post Staff

  • May 14, 2026

  • 3 min

Share

A recent systematic review and meta-analysis published in JAMA Network Open indicates that early time-of-day immunotherapy markedly enhances survival rates in patients with advanced cancers, particularly in non-small cell lung cancer, renal cell carcinoma, gastric cancer, small cell lung cancer, and biliary tract cancer. Researchers highlight that circadian rhythms may influence immune responses, making treatment timing a potentially relevant factor in immunotherapy. Further prospective studies are essential to confirm these findings and establish timing protocols.

Original Source(s)

Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?

  • by The ASCO Post Staff

  • May 14, 2026

Related Content

Combination Enzalutamide and Radium-223 Extends Overall Survival in Bone-Dominant mCRPC

In the final analysis of the phase III EORTC 1333/PEACE-3 trial, with a median follow-up of 58 months, the addition of radium-223 to the androgen receptor inhibitor enzalutamide significantly prolonge...

Lack of Research in Understanding the Global Population of Childhood Cancer Survivors Leads to Gaps in Care and Cures

Each year, globally, about 400,000 children and adolescents aged between 0 and 19 years are diagnosed with cancer; over 100,000 die from the disease, with most of those cases, over 80%, and deaths occ...

New Clues in Hodgkin Lymphoma Biology

Transcriptome analysis highlights diagnostic targets and immune evasion pathways

  • May 14, 2026

  • 2 min